Oncologic and obstetric outcomes of early‐stage epithelial ovarian cancer patients who underwent fertility‐sparing surgery: A retrospective study
International Journal of Gynecology & Obstetrics · 2023-08 · 162 (2) · 711-717
DOI: 10.1002/ijgo.14732 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 23.03.2023. Verfasst von Ali Ayhan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Başkent University Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Fertility Preservation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
This study aimed to assess the long‐term oncologic and obstetric outcomes of women with epithelial ovarian cancer who underwent fertility‐sparing surgery.
Methods
A total of 68 patients observed between March 2007 and July 2021 were included in this retrospective study. Unilateral salpingo‐oophorectomy and uterine preservation with staging surgery were the main procedures for fertility‐sparing surgery. Disease‐free, overall survival, and obstetric outcomes were measured as primary outcomes.
Results
The median age of the patients was 30.5 years. The median follow‐up time was 60.5 months. Disease recurrence occurred in 15 (22.1%) of the patients. Five‐year disease‐free survival and overall survival (OS) percentages were 75.6% and 83.3%, respectively, for all stages. The FIGO (International Federation of Gynecology & Obstetrics) stage was the only significant factor that affected OS ( P = 0.001). Twenty‐three patients tried to conceive, and 15 (65.2%) patients became pregnant. Twelve (80%) pregnancies reached term and resulted in 15 live births. Chemotherapy administration and surgical intervention (cystectomy or unilateral salpingo‐oophorectomy) showed no difference in pregnancy results ( P = 0.806 and P = 0.066, respectively).
Conclusion
Fertility preservation is safe for invasive epithelial ovarian cancer at early stages for women in the reproductive era. Disease recurrence and OS results are similar to standard treatment at early stages with decent obstetric outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Başkent University Hospital, Ankara, Turkey.
- Department of Pathology, Başkent University Hospital, Ankara, Turkey.
ORCID-Profile: Ali Ayhan, Mehmet Tunç, Latife Atasoy Karakaş, Tuğba Tekelioğlu, Asuman Nihan Haberal Reyhan, Göğşen Önalan, Esra Kuşçu
Zitieren
APA
Ayhan, A., Tunç, M., Atasoy Karakaş, L., Tekelioğlu, T., Haberal Reyhan, A. N., Önalan, G., & Kuşçu, E. (2023). Oncologic and obstetric outcomes of early‐stage epithelial ovarian cancer patients who underwent fertility‐sparing surgery: A retrospective study. International Journal of Gynecology & Obstetrics, 162(2), 711-717. https://doi.org/10.1002/ijgo.14732
Vancouver
Ayhan A, Tunç M, Atasoy Karakaş L, Tekelioğlu T, Haberal Reyhan AN, Önalan G, et al. Oncologic and obstetric outcomes of early‐stage epithelial ovarian cancer patients who underwent fertility‐sparing surgery: A retrospective study. International Journal of Gynecology & Obstetrics. 2023;162(2):711-717. doi:10.1002/ijgo.14732
BibTeX
@article{Ayhan2023,
author = {Ayhan, Ali and Tunç, Mehmet and Atasoy Karakaş, Latife and Tekelioğlu, Tuğba and Haberal Reyhan, Asuman Nihan and Önalan, Göğşen and Kuşçu, Esra},
title = {Oncologic and obstetric outcomes of early‐stage epithelial ovarian cancer patients who underwent fertility‐sparing surgery: A retrospective study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2023},
volume = {162},
number = {2},
pages = {711--717},
doi = {10.1002/ijgo.14732}
}
EUVIMED